Related Experiment Videos
Topical retinoids: in vivo predictive assays
Journal of the American Academy of Dermatology
|October 1, 1986
Summary
This review discusses preclinical assays for evaluating new vitamin A derivatives, known as retinoids, for treating skin conditions like acne and psoriasis. These assays help predict retinoid efficacy and manage potential toxicities.
Area of Science:
- Dermatology
- Pharmacology
- Toxicology
Background:
- Vitamin A is crucial for skin cell growth and function.
- Retinoids, synthetic vitamin A derivatives, treat various skin conditions such as acne, ichthyosis, Darier's disease, and psoriasis.
- Existing retinoids can be toxic, necessitating the development and evaluation of new derivatives.
Purpose of the Study:
- To review preclinical assays for evaluating the efficacy of novel retinoids.
- To identify assays that can predict the therapeutic potential of new vitamin A derivatives.
- To address the need for safer and more effective retinoid therapies.
Main Methods:
- Discussion of various in vivo animal assays.
- Evaluation of selective biological properties of retinoids.
- Assessment of efficacy in different preclinical models.
Main Results:
- The review highlights the importance of in vivo assays in predicting retinoid efficacy.
- Different retinoids exhibit distinct biological properties that can be selectively assessed.
- Preclinical assays are essential for identifying promising new retinoid candidates.
Conclusions:
- Appropriate preclinical assays are vital for the successful development of new retinoid therapies.
- Selecting the right assays can help optimize retinoid efficacy and minimize toxicity.
- This review provides a guide to useful assays for predicting retinoid effectiveness in skin disease treatment.